Keyword: Warner Chilcott

News

US Inversion Plan Could Scupper Pfizer-Allergan

06.04.2016 - What a difference a day makes. On Apr. 3, European time, Pfizer and Allergan said the US Federal Trade Commission’s deeper probe into their potential merger, the so-called second...

News

Actavis Changing Name to Allergan

19.02.2015 - Three months after acquiring US Botox producer Allergan for $66 billion, Ireland-based drugmaker Actavis has announced it will adopt Allergan as the name of the merged corporate...

News

Actavis to Buy Forest Labs for $25 billion

21.02.2014 - Dublin, Ireland-based generic drugmaker Actavis is acquiring specialty pharmaceuticals company Forest Laboratories of New York in a cash and stock deal valued at about $25 billion...

News

Amgen Buys Onyx for $10.4 Billion

26.08.2013 - Amgen struck a deal to buy cancer drug maker Onyx Pharmaceuticals for about $10.4 billion on Sunday, as it moves to restock its product pipeline in response to declining sales of...

News

Onyx Rejects Amgen Offer, Explores Possible Sale

01.07.2013 - Cancer drugmaker Onyx Pharmaceuticals said on Sunday it rejected a roughly $10 billion takeover offer from larger biotechnology company Amgen as too low but still is considering...

News

Actavis to Buy Warner Chilcott in $5 Billion Stock Deal

20.05.2013 - Generic drugmaker Actavis, which has been the subject of takeover speculation, plans to buy specialty pharmaceutical company Warner Chilcott for $5 billion in stock. The companies...

News

Endo Health in Talks with Potential Buyers

31.01.2013 - Endo Health Solutions has held talks in recent weeks with drugmakers potentially interested in buying the maker of pain relief medication, people familiar with the matter said on...

News

Bayer Sues Warner Chilcott for Patent Infringement

20.08.2012 - Warner Chilcott said German drugmaker Bayer filed a complaint against the U.S. pharmaceutical company, alleging that Warner's oral contraceptive drug Lo Loestrin FE infringes a...